Splitomicin
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- SIRT1 inhibitor
- Produktmerkmale
- Initially shown to inhibit Sir2p (the yeast Sirt1 homolog) and create a conditional phenocopy of a sir2 deletion mutant in S. cerevisiae. Cells grown in the presence of the drug have silencing defects at telomeres, silent mating-type loci and the ribosomal DNA. Inhibits all class III HDACs (sirtuins) and alleviates gene silencing in Fragile X mental retardation syndrome. Reverses ischemic preconditioning-induced cardioprotection in a mouse model.
- Reinheit
- >98 %
- Chemical Name
- 1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one
- Formel
- C13H10O2
- Löslichkeit
- Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- RT
-
- Hintergrund
- Splitomycin,Epigenetics,Protein deacetylase,Ischemia,Heart disease,Posttranslational modification,Chromatin
- Molekulargewicht
- 198.22
- CAS-Nummer
- 5690-03-9
-